Telitacicept in combination with standard therapy was effective for the treatment of systemic lupus erythematosus through 52 weeks.

Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...

GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on ...

Galapagos (GLPG) announced the topline results from two Phase 3-enabling studies evaluating the efficacy and safety of GLPG3667, a selective TYK2 ...

Environmental exposures are emerging as major contributors to autoimmune risk: Studies link air pollution, PFAS, and ...

FDA approves AstraZeneca and Daiichi's Enhertu combo for first-line HER2-positive breast cancer, while the EU clears Saphnelo ...

Patients with systemic lupus erythematosus and diabetes who received sodium-glucose cotransporter 2 inhibitors exhibited ...

A Kathleen family is sharing its medical journey as a local holiday event raises money to help cover ongoing treatment.

A recent review highlights melatonin's potential in diagnosing and treating systemic lupus erythematosus (SLE). Research indicates lower serum melatonin levels in SLE patients, suggesting diagnostic ...

Following this week's European Commission approval of Roche/Genentech's Gazyvaro (obinutuzumab) for the treatment of lupus nephritis (LN), Spherix Global Insights' latest RealTime Dynamix(TM): Lupus ...

Roche has received approval from the European Commission (EC) for its humanised monoclonal antibody Gazyva/Gazyvaro ...

In a new study, researchers examined the Renal Activity Index for Lupus (RAIL) diagnostic tool to assess its success for ...